KIT and leukemia: That some MYB target genes (such as KIT, CDK6 and FLT3) exhibit a degree of correlation with MYB levels amongst the patient datasets probably reflects a wide range of driver mutations and a very heterogeneous genetic landscape amongst the complex karyotype leukaemias.